Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/16/2012CN102451155A Prescription and preparation method of docetaxel injection
05/16/2012CN101756895B Polyene phosphatidyl choline intravenous preparation and preparation method thereof
05/16/2012CN101574507B Nasal administration system for treating headache
05/16/2012CN101513400B Ampelopsin and basic amino acid solubilizing system and antitumor activity research
05/16/2012CN101306019B Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
05/16/2012CN101147725B Ketoconazole suppository composition for vaginal administration
05/15/2012US8178663 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178656 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents
05/15/2012US8178617 Antimicrobial constructs
05/15/2012US8178609 Isoflavones for treating mucopolysaccharidoses
05/15/2012US8178576 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
05/15/2012US8178519 Antiinflammatory agents; heating glucocorticoid with water and surfactant
05/15/2012US8178518 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
05/15/2012US8178499 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/15/2012US8178121 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
05/15/2012US8178115 Method and composition for the treatment of scars
05/15/2012US8178112 Ketoprofen compositions and methods of making them
05/15/2012US8178088 Antiprotozoal composition
05/15/2012CA2717605C Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
05/15/2012CA2647360C Methods and compositions for deterring abuse of orally administered pharmaceutical products
05/15/2012CA2542726C Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/15/2012CA2536281C Ophthalmic composition comprising a 15-keto-prostaglandin compound
05/15/2012CA2526616C Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
05/15/2012CA2511849C Stable topical drug delivery compositions comprising a multilamellar liquid crystal phosphatidylcholine carrier
05/15/2012CA2487332C Quaternised ammonium cyclodextrin compounds for use as antimicrobial agents, preservatives and penetration enhancers
05/15/2012CA2482787C Temperature responsive delivery systems
05/15/2012CA2479351C Topical composition comprising a cyclofructan, a carrier and a drug
05/15/2012CA2477593C Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases
05/15/2012CA2470500C Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
05/15/2012CA2461730C Novel cyclosporin analog microemulsion preconcentrates
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2437899C Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
05/15/2012CA2433679C Polymer coated microparticles for sustained release
05/15/2012CA2430816C Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
05/15/2012CA2398229C Improved dna vaccines for production-type animals
05/15/2012CA2365536C Compositions and methods for improved delivery of hydrophobic therapeutic agents
05/15/2012CA2219931C Stabilized standards and calibrators
05/10/2012WO2012061703A1 Compositions and methods relating to reduced mucoadhesion
05/10/2012WO2012061443A2 Compositions of a peptide-based system for cell-specific targeting
05/10/2012WO2012061402A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012WO2012061360A2 Pharmaceutical compositions
05/10/2012WO2012060431A1 Patch
05/10/2012WO2012060376A1 Felbinac-containing external patch
05/10/2012WO2012060111A1 Non-reducing end-modified glucan, method for producing same, and use thereof
05/10/2012WO2012060110A1 Amino sugar-containing glucan, method for producing same and use of same
05/10/2012WO2012059937A1 Modifies release pharmaceutical compositons for nsaids
05/10/2012WO2012059936A1 Pharmaceutical compositions for colloidal drug delivery
05/10/2012WO2012059882A2 Engineered polypeptide conjugates and methods for making thereof using transglutaminase
05/10/2012WO2012059873A2 Anti-diabetic compounds
05/10/2012WO2012059820A1 Temperature sensitive hydrogel and block copolymers
05/10/2012WO2012059689A1 Compressible, highly viscous polysaccharide and polyol powder
05/10/2012WO2012059584A1 High-efficiency catalysts, preparation and use thereof
05/10/2012WO2012059573A1 Immunogenic peptide
05/10/2012WO2012024634A3 Environmentally-responsive nanocomposites and methods of their use
05/10/2012WO2012018383A3 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
05/10/2012WO2012018380A3 Compositions and methods for inducing immune tolerance
05/10/2012WO2012018377A3 Liposome targeting compounds and related uses
05/10/2012WO2012016181A3 Anti-allergy lozenges
05/10/2012WO2011130462A3 Intraocular pressure reduction with intracameral bimatoprost implants
05/10/2012WO2011128635A3 Anti-abuse pharmaceutical compositions
05/10/2012WO2011128631A3 Vegetarian oral pharmaceutical and nutraceutical compositions
05/10/2012WO2011116286A4 Stable bortezomib formulations
05/10/2012WO2011112875A3 Foamable formulation
05/10/2012WO2011109415A3 Reducing viscosity of pharmaceutical formulations
05/10/2012WO2011064271A4 Use of an oleo gel containing triterpene for healing wounds
05/10/2012US20120115964 Xanthan gum and swellable particulate containing composition and uses thereof
05/10/2012US20120115963 Polymer nanoparticles
05/10/2012US20120115962 Cyclodextrin-modified polyamines for delivery of therapeutic molecules
05/10/2012US20120115961 Metal organic framework compounds
05/10/2012US20120115958 Liquid pharmaceutical formulation containing paracetamol
05/10/2012US20120115957 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/10/2012US20120115950 Abuse-resistant amphetamine prodrugs
05/10/2012US20120115812 Surface coatings for skin
05/10/2012US20120115796 Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds
05/10/2012US20120115729 Process for forming films, fibers, and beads from chitinous biomass
05/10/2012US20120114831 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
05/10/2012US20120114759 Peptide/particle delivery systems
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114717 Tableting agent having a low water content, and method for the production thereof
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114709 Formulations for use in inhaler devices
05/10/2012US20120114705 Water soluble film for oral administration with instant wettability
05/10/2012US20120114692 Immunogenic compositions containing phospholipid
05/10/2012US20120114674 Molecular Antigen Array
05/10/2012US20120114662 Human monoclonal antibodies against bacillus anthracis protective antigen
05/10/2012US20120114615 Hydrolytically degradable polysaccharide hydrogels
05/10/2012US20120114590 Il28 and il29 truncated cysteine mutants and antiviral methods of using same
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120114547 Stabilization and ionic triggering of nitric oxide release
05/10/2012CA2816957A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816808A1 High-efficiency catalysts, preparation and use thereof
05/10/2012CA2816681A1 Cytotoxic agents comprising new ansamitocin derivatives
05/10/2012CA2816584A1 Compositions of a peptide-based system for cell-specific targeting
05/10/2012CA2816322A1 Isoflavonoid compositions and methods for the treatment of cancer
05/10/2012CA2816123A1 Compositions and methods for the delivery of therapeutics
05/10/2012CA2816121A1 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012CA2816077A1 Pharmaceutical compositions
05/10/2012CA2815967A1 Anti-diabetic compounds
05/10/2012CA2815792A1 Felbinac-containing external patch
1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 1712